Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Wells Fargo Analyst Upgrades Price Target for Chart Industries NYSE GTLS

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Investings on laptops and finances
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, Wells Fargo analyst Roger Read reiterated his positive stance on Chart Industries (NYSE: GTLS), upgrading the price target from $155 to $172. This comes after Wells Fargo initially covered the stock with an Overweight rating and a price target of $230, suggesting a potential upside of 14.3%. Furthermore, the price target was adjusted upward to $226 from $224 while maintaining the Overweight rating. These adjustments indicate Wells Fargo’s strong belief in Chart Industries’ performance and growth prospects.

Chart Industries, Inc. (GTLS) Stock Shows Positive Momentum on March 2, 2024

On March 2, 2024, Chart Industries, Inc. (GTLS) showed positive momentum in its stock performance. The stock closed at $146.58, which was $3.72 higher than the previous market close, representing a 2.60% increase. This upward movement is a promising sign for investors, indicating potential growth in the company’s value.

GTLS is currently trading in the middle of its 52-week range, suggesting that there is room for further price movements in either direction. Additionally, the stock is trading above its 200-day simple moving average, indicating a positive long-term trend in its price performance.

However, it is worth noting that GTLS experienced a slight drop of $0.58 in after-hours trading. While this drop may cause some concern among investors, it is important to consider that after-hours trading can be more volatile and may not always accurately reflect the stock’s overall performance. Investors should continue to monitor the stock’s movement and consider other factors such as market trends and company news to make informed investment decisions.

GTLS Stock Performance Analysis: Revenue and Net Income Increase, EPS Decrease – March 2, 2024

On March 2, 2024, GTLS stock had some interesting performances based on the financial data provided by CNN Money. The total revenue for the company was reported to be $3.35 billion for the past year and $1.01 billion for the last quarter.

Net income for GTLS was reported to be $47.70 million for the past year and $47.80 million for the last quarter.

Earnings per share (EPS) for GTLS were reported to be $0.44 for the past year and $0.98 for the last quarter.

Overall, the financial performance of GTLS on March 2, 2024, shows a mixed picture. While the company has seen significant growth in total revenue and net income, there are some concerns about the decrease in EPS. Investors will likely be keeping a close eye on future earnings reports to see if the company can continue its positive momentum and address any potential issues.

Tags: GTLS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Annexon Inc Receives Upgrade from JP Morgan and Positive Outlook for GBS Treatment

Finance_Banking (2)

Analyst Chris Parkinson from Wolfe Research Rates Element Solutions as Peer Perform

Healthcare-sector

Elevance Health Stands by 2024 Forecast with Strong Financial Results

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com